Evaluation of azithromycin in systemic and toothpaste forms for the treatment of ciclosporin-associated gingival overgrowth in dogs

Veterinary Dermatology

Volumn 24, Issue 3, 2013, Pages

  Rosenberg, Andrew ^a   Rosenkrantz, Wayne ^a   Griffin, Craig ^b   Angus, John ^c   Keys, Deborah ^d  

^a Animal Dermatology Clinic   (United States)

^b Animal Dermatology Clinic   (United States)

^c Animal Dermatology Clinic   (United States)

^d Independent statistical consultant   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; CHEMICALLY INDUCED DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DOG DISEASE; DRUG DOSAGE FORM; FEMALE; GINGIVA OVERGROWTH; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CYCLOSPORINE; DOG DISEASES; DOGS; DOSAGE FORMS; FEMALE; GINGIVAL OVERGROWTH; IMMUNOSUPPRESSIVE AGENTS; MALE;

EID: 84877878094     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/vde.12033     Document Type: Article

References (44)

1. Mascarell L, Truffa-Bachi P. New aspects of cyclosporin A mode of action: from gene silencing to gene up-regulation. Mini Rev Med Chem 2003; 3: 205-214.
2. Steffan J, Alexander D, Brovedani F et al. Comparison of cyclosporine A with methylprednisolone for treatment of canine atopic dermatitis: a parallel, blinded, randomized controlled trial. Vet Dermatol 2003; 14: 11-22.
3. Steffan J, Parks C, Seewald W. Clinical trial evaluating the efficacy and safety of cyclosporine in dogs with atopic dermatitis. J Am Vet Med Assoc 2005; 226: 1855-1863.
4. Olivry T, Steffan J, Fisch RD et al. Randomized controlled trial of the efficacy of cyclosporine in the treatment of atopic dermatitis in dogs. J Am Vet Med Assoc 2002; 221: 370-377.
5. Kovalik M, Taszkun I, Pomorski Z et al. Evaluation of a human generic formulation of ciclosporin in the treatment of canine atopic dermatitis with in vitro assessment of the functional capacity of phagocytic cells. Vet Rec 2011; 168: 537.
6. Mathews KA, Ayres SA, Tano CA et al. Cyclosporin treatment of perianal fistulas in dogs. Can Vet J 1997; 38: 39-41.
7. House AK, Guitian J, Gregory SP et al. Evaluation of the effect of two dose rates of cyclosporine on the severity of perianal fistulae lesions and associated clinical signs in dogs. Vet Surg 2006; 35: 543-549.
8. Linek M, Boss C, Haemmerling R et al. Effects of cyclosporine A on clinical and histologic abnormalities in dogs with sebaceous adenitis. J Am Vet Med Assoc 2005; 226: 59-64.
9. Kovalik M, Thoday KL, van den Broek AH. The use of ciclosporin A in veterinary dermatology. Vet J 2012; 193: 317-325.
10. Roberts E. Atopica pharmacovigilance: a review of the canine data, Proceeding of a Novartis Animal Health Dermatology Symposium held at the World Congress of Veterinary Dermatology, 2012: 22-23.
11. Nam HS, McAnulty JF, Kwak HH et al. Gingival overgrowth in dogs associated with clinically relevant cyclosporine blood levels: observations in a canine renal transplantation model. Vet Surg 2008; 37: 247-253.
12. Steffan J, Favrot C, Mueller R. A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs. Vet Dermatol 2006; 17: 3-16.
13. Namikawa K, Maruo T, Honda M et al. Gingival overgrowth in a dog that received long-term cyclosporine for immune-mediated hemolytic anemia. Can Vet J 2012; 53: 67-70.
14. Lewis JR, Reiter AM. Management of generalized gingival enlargement in a dog-case report and literature review. J Vet Dent 2005; 22: 160-169.
15. Somacarrera ML, Hernandez G, Acero J et al. Factors related to the incidence and severity of cyclosporin-induced gingival overgrowth in transplant patients. A longitudinal study. J Periodontol 1994; 65: 671-675.
16. Pernu HE, Pernu LM, Huttunen KR et al. Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and possible local background factors. J Periodontol 1992; 63: 548-553.
17. Williamson MS, Miller EK, Plemons J et al. Cyclosporine A upregulates interleukin-6 gene expression in human gingiva: possible mechanism for gingival overgrowth. J Periodontol 1994; 65: 895-903.
18. Schincaglia GP, Forniti F, Cavallini R et al. Cyclosporin-A increases type I procollagen production and mRNA level in human gingival fibroblasts in vitro. J Oral Pathol Med 1992; 21: 181-185.
19. Nash MM, Zaltzman JS. Efficacy of azithromycin in the treatment of cyclosporine-induced gingival hyperplasia in renal transplant recipients. Transplantation 1998; 65: 1611-1615.
20. Ljutic D, Rumboldt Z. Possible interaction between azithromycin and cyclosporin: a case report. Nephron 1995; 70: 130.
21. Zwerner TJ. Mosby's Dental Dictionary. St Louis, MO: Mosby, 1998; 245.
22. Carranza FA, Hogan EL. Gingival enlargement. In: Newman MG, Takei HH, Klokkevold PR et al. Carranza's Clinical Periodontology, 11th edn. Philadelphia, PA: W.B. Saunders, 2012: 84-96.
23. Angelopoulos AP, Goaz PW. Incidence of diphenylhydantoin gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1972; 34: 898-906.
24. Wahlstrom E, Zamora JU, Teichman S. Improvement in cyclosporine-associated gingival hyperplasia with azithromycin therapy. N Engl J Med 1995; 332: 753-754.
25. Puig JM, Lloveras J, Bosch JM et al. Treatment of gingival hyperplasia secondary to cyclosporine by the new macrolide azithromycin. Transplant Proc 1997; 29: 2379-2380.
26. Tokgöz B, Sari HI, Yildiz O et al. Effects of azithromycin on cyclosporine-induced gingival hyperplasia in renal transplant patients. Transplant Proc 2004; 36: 2699-2702.
27. Argani H, Pourabbas R, Hassanzadeh D et al. Treatment of cyclosporine-induced gingival overgrowth with azithromycin-containing toothpaste. Exp Clin Transplant 2006; 4: 420-424.
28. Gladue RP, Snider ME. Intracellular accumulation of azithromycin by cultured human fibroblasts. Antimicrob Agents Chemother 1990; 34: 1056-1060.
29. Conde SA, Aarestrup FM, Vieira BJ et al. Roxithromycin reduces cyclosporine-induced gingival hyperplasia in renal transplant patients. Transplant Proc 2008; 40: 1435-1438.
30. Peri FA, Daibert AP, Bourguignon E et al. Periodontal disease in dogs. In: Perez-Marin CC ed. A Bird's Eye View of Veterinary Medicine. Rijeka, Croatia: InTech, 2012: 119-140.
31. Gómez E, Sánchez-Nuñez M, Sánchez JE et al. Treatment of cyclosporin-induced gingival hyperplasia with azithromycin. Nephrol Dial Transplant 1997; 12: 2694-2697.
32. Yaǧci BB, Ural K, Ocal N et al. Azithromycin therapy of papillomatosis in dogs: a prospective, randomized, double-blinded, placebo-controlled clinical trial. Vet Dermatol 2008; 19: 194-198.
33. Birkenheuer AJ, Levy MG, Breitschwerdt EB. Efficacy of combined atovaquone and azithromycin for therapy of chronic Babesia gibsoni (Asian genotype) infections in dogs. J Vet Intern Med 2004; 18: 494-498.
34. Cook AK, Nieuwoudt CD, Longhofer SL. Pharmaceutical evaluation of compounded trilostane products. J Am Anim Hosp Assoc 2012; 48: 228-233.
35. Umstead ME, Boothe DM, Cruz-Espindola C et al. Accuracy and precision of compounded ciclosporin capsules and solution. Vet Dermatol 2012; 23: 431-e82.
36. Gonwa TA, Nghiem DD, Schulak JA et al. Erythromycin and cyclosporine. Transplantation 1986; 41: 797-799.
37. von Rosensteil NA, Adam D. Macrolide antibacterials. Drug interactions of clinical significance. Drug Saf 1995; 13: 105-122.
38. Page RL 2nd, Ruscin JM, Fish D et al. Possible interaction between intravenous azithromycin and oral cyclosporine. Pharmacotherapy 2001; 21: 1436-1443.
39. Amacher DE, Schomaker SJ, Retsema JA. Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450. Antimicrob Agents Chemother 1991; 35: 1186-1190.
40. Pessayre D. Effects of macrolide antibiotics on drug metabolism in rats and in humans. Int J Clin Pharmacol Res 1983; 3: 449-458.
41. Shepard RM, Falkner FC. Pharmacokinetics of azithromycin in rats and dogs. J Antimicrob Chemother 1990; 25(Suppl A): 49-60.
42. Dahlinger J, Gregory C, Bea J. Effect of ketoconazole on cyclosporine dose in healthy dogs. Vet Surg 1998; 27: 64-68.
43. Gray L, Hillier A, Cole L et al. The effect of ketoconazole on whole blood and skin ciclosporin concentrations in canines. Vet Dermatol 2013; 24: 118-125.e27-e28.
44. Katayama M, Igarashi H, Tani K et al. Effect of multiple oral dosing of fluconazole on the pharmacokinetics of cyclosporine in healthy beagles. J Vet Med Sci 2008; 70: 85-88.